We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · August 26, 2020

Effect of Sustained-Release Morphine for Refractory Breathlessness in COPD on Health Status

JAMA internal medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA internal medicine
Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial
JAMA Intern Med 2020 Aug 17;[EPub Ahead of Print], CA Verberkt, MHJ van den Beuken-van Everdingen, JMGA Schols, N Hameleers, EFM Wouters, DJA Janssen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading